0001144204-17-026954.txt : 20170512 0001144204-17-026954.hdr.sgml : 20170512 20170512171935 ACCESSION NUMBER: 0001144204-17-026954 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170511 FILED AS OF DATE: 20170512 DATE AS OF CHANGE: 20170512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Moleculin Biotech, Inc. CENTRAL INDEX KEY: 0001659617 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474671999 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2575 WEST BELLFORT STREET 2: SUITE 333 CITY: HOUSTON STATE: TX ZIP: 77054 BUSINESS PHONE: 713-300-5160 MAIL ADDRESS: STREET 1: 2575 WEST BELLFORT STREET 2: SUITE 333 CITY: HOUSTON STATE: TX ZIP: 77054 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KLEMP WALTER V CENTRAL INDEX KEY: 0000938419 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37758 FILM NUMBER: 17839947 MAIL ADDRESS: STREET 1: 1415 WEST LOOP NORTH CITY: HOUSTON STATE: TX ZIP: 77055 4 1 v466826_form4.xml FORMO 4 X0306 4 2017-05-11 0 0001659617 Moleculin Biotech, Inc. MBRX 0000938419 KLEMP WALTER V C/O MOLECULIN BIOTECH, INC. 2575 WEST BELLFORT, SUITE 333 HOUSTON TX 77054 1 1 1 0 Chief Executive Officer Common Stock 2017-05-11 4 P 0 12000 0.81 A 1067724 D In addition to the shares held directly by the reporting person, the reporting person is the majority shareholder and control person of Annamed, Inc. Annamed, Inc. holds 1,425,000 shares of Issuer common stock. The Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by Annamed, Inc. /s/ Walter Klemp 2017-05-11